Your browser doesn't support javascript.
loading
Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings.
Cyrta, Joanna; Gauthier, Arnaud; Karanian, Marie; Vieira, Andre F; Cardoen, Liesbeth; Jehanno, Nina; Bouvet, Mégane; Bouvier, Corinne; Komuta, Mina; Le Loarer, François; Orbach, Daniel; Rome, Angélique; Minard-Colin, Véronique; Brichard, Bénédicte; Pluchart, Claire; Thebaud, Estelle; Renard, Marleen; Pannier, Stéphanie; Brisse, Hervé; Petit, Philippe; Benoist, Camille; Schleiermacher, Gudrun; Geoerger, Birgit; Vincent-Salomon, Anne; Fréneaux, Paul; Pierron, Gaëlle.
Afiliación
  • Cyrta J; Departments of Pathology.
  • Gauthier A; Departments of Pathology.
  • Karanian M; Department of Pathology, Lyon University Hospital, Lyon.
  • Vieira AF; Departments of Pathology.
  • Cardoen L; Imaging.
  • Jehanno N; Nuclear Medicine.
  • Bouvet M; Genetics Unit, Department of Tumor Biology.
  • Bouvier C; Departments of Pathology.
  • Komuta M; Departments of Pathology.
  • Le Loarer F; Department of Pathology, School of Medicine, Keio University, Tokyo, Japan.
  • Orbach D; Department of Pathology, Bergonié Institute, Bordeaux.
  • Rome A; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA With Cancer), Curie Institute, PSL Research University.
  • Minard-Colin V; Pediatric and Adolescent Hematogy and Oncology.
  • Brichard B; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, INSERM U1015, Paris-Saclay University, Villejuif.
  • Pluchart C; Pediatric Hematology/Oncology, University Hospital Saint-Luc, Catholic University of Leuven, Brussels, Belgium.
  • Thebaud E; Department of Paediatric Oncology/Hematology, American Hospital, University Hospital of Reims, Reims, France.
  • Renard M; Department of Pediatric Hemato-oncology, University Hospital of Nantes, Nantes.
  • Pannier S; Pediatric Hematology/Oncology, University Hospital Saint-Luc, Catholic University of Leuven, Brussels, Belgium.
  • Brisse H; Department of Orthopedic Surgery, University Hospital Necker-Enfants-Malades, Paris.
  • Petit P; Imaging.
  • Benoist C; Radiology, La Timone Hospital, Aix Marseille University, Marseille.
  • Schleiermacher G; Biopathology and Genetics.
  • Geoerger B; SIREDO Oncology Center (Care, Innovation and Research for Children and AYA With Cancer), Curie Institute, PSL Research University.
  • Vincent-Salomon A; Department of Pediatric and Adolescent Oncology, Gustave Roussy Cancer Campus, INSERM U1015, Paris-Saclay University, Villejuif.
  • Fréneaux P; Departments of Pathology.
  • Pierron G; Departments of Pathology.
Am J Surg Pathol ; 45(6): 854-867, 2021 06 01.
Article en En | MEDLINE | ID: mdl-33949344
ABSTRACT
VGLL2-rearranged rhabdomyosarcomas (RMS) are rare low-grade tumors with only favorable outcomes reported to date. We describe 4 patients with VGLL2-rearranged RMS confirmed by molecular studies, who experienced local progression and distant metastases, including 2 with fatal outcomes. Tumors were diagnosed at birth (n=3) or at 12 months of age (n=1), and were all localized at initial diagnosis, but unresectable and therefore managed with chemotherapy and surveillance. Metastatic progression occurred from 1 to 8 years from diagnosis (median, 3.5 y). Three patients experienced multimetastatic spread and one showed an isolated adrenal metastasis. At initial diagnosis, 3 tumors displaying bland morphology were misdiagnosed as fibromatosis or infantile fibrosarcoma and initially managed as such, while 1 was a high-grade sarcoma. At relapse, 3 tumors showed high-grade morphology, while 1 retained a low-grade phenotype. Low-grade primary tumors showed only very focal positivity for desmin, myogenin, and/or MyoD1, while high-grade tumors were heterogenously or diffusely positive. Whole-exome sequencing, performed on primary and relapse samples for 3 patients, showed increased genomic instability and additional genomic alterations (eg, TP53, CDKN2A/B, FGFR4) at relapse, but no recurrent events. RNA sequencing confirmed that high-grade tumors retained VGLL2 fusion transcripts and transcriptomic profiles consistent with VGLL2-rearranged RMS. High-grade samples showed a high expression of genes encoding cell cycle proteins, desmin, and some developmental factors. These 4 cases with distinct medical history imply the importance of complete surgical resection, and suggest that RMS-type chemotherapy should be considered in unresectable cases, given the risk of high-grade transformation. They also emphasize the importance of correct initial diagnosis.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rabdomiosarcoma / Factores de Transcripción / Reordenamiento Génico / Biomarcadores de Tumor / Proteínas Musculares Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Female / Humans / Infant / Male / Newborn País/Región como asunto: Europa Idioma: En Revista: Am J Surg Pathol Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Rabdomiosarcoma / Factores de Transcripción / Reordenamiento Génico / Biomarcadores de Tumor / Proteínas Musculares Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Female / Humans / Infant / Male / Newborn País/Región como asunto: Europa Idioma: En Revista: Am J Surg Pathol Año: 2021 Tipo del documento: Article
...